Mouse Placental Lactogen ELISA Kit

Objective: Rare co-existance of disease or pathology Background: Essential thrombocythemia (ET) is a type of myeloproliferative neoplasm (MPN) characterized by sustained thrombocytosis in peripheral blood. Patients typically have gene mutations like JAK2V617F, CALR, and MPLW515L/K. This report describes a young man with ET without any of the above mutations who had paradoxical bleeding due to acquired Von-Willebrand disease. Case Report: A young man with a medical history of thrombocytosis on aspirin presented with acute chest pain and was found to have had a myocardial infarction. Emergency cardiac catheterization revealed a thrombotic occlusion of the left anterior descending (LAD) artery and the right posteriolateral system, with an ejection fraction of 25%. He underwent thrombectomy and balloon angioplasty with LAD stenting, and an Impella 2.5 was inserted due to severe left ventricular dysfunction with akinesia. Aspirin and ticagrelor were administered, but the patient later experienced postoperative bleeding from the site of the Impella device. The bleeding was attributed to acquired Von-Willebrand disease secondary to ET. Emergency plateletpheresis was recommended. Further workup demonstrated that he was triple-negative for JAK2, MPL, and CALR gene mutations. Conclusions: The paradoxical bleeding resulting from acquired Von-Willebrand disease was likely an entirely separate entity from the hyper-thrombotic state expected from ET. Careful assessment of clinical symptoms and laboratory markers, in addition to a high degree of suspicion, are needed to diagnose acquired Von-Willebrand disease as a complication of ET.

We report levels of trace elements in commercially harvested species from the Far Eastern seas of Russia from 2010 to 2018. The best studied organisms in this region are algae and fish, and the least studied are crustaceans. The trace element content in target species of marine fisheries generally meets the standards of sanitary rules and norms established by the Russian Federation. However, in some cases, the maximum permissible levels (MPL) are exceeded for lead in algae and fish, cadmium in fish, and arsenic in crustaceans, which indicates the necessity to continue monitoring the commercial marine organisms. The requirements for seafood quality in Russia and the European Union (EU) are compared. European MPL limits are stricter for cadmium and lead concentrations. Also, the EU regulations do not have MPLs of arsenic (As) for all marine organisms, which is explained by the predominance of the low-toxic organic form of As in them. Thus, the regulatory documentation in Russia needs to be updated; also, a nationally standardized method of separate determination of organic and inorganic As forms should be created.